ADC THERAPEUTICS SA
ADCT · NYSE
更新於 2026-10-14 09:06:44
$1.70-8.6%
- 今日最高
- $1.86
- 今日最低
- $1.62
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $1.70
- 昨天收盤價
- $1.86
- 成交量
- 1.59M
- 市值
- $237.46M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.72
昨天價格區間
$1.64$1.87
52週價格區間
$0.77$4.98
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 藥品製造商 - 專科及仿製藥
- 總部
- BIOPOLE, EPALINGES, SWITZERLAND, 1066
- 國家
- CH
- 上市日期
- 2020-05-15
- 財年截止
- 十二月
- 流通股數
- 127.19M
- CIK
- 0001771910
ADC Therapeutics SA 是一家專注於臨床階段腫瘤學的生物科技公司，開發抗體藥物偶聯物（ADC），用於治療患有血液惡性腫瘤及實體腫瘤的患者。公司總部位於瑞士埃帕蘭日。
財務指標
營業收入
2026-06-30
$19.24M
2026-03-31
$20.03M
2025-12-31
$23.05M
2025-09-30
$16.42M
營業支出
2026-06-30
$42.31M
2026-03-31
$41.66M
2025-12-31
$39.48M
2025-09-30
$45.55M
淨利潤
2026-06-30
-$16.56M
2026-03-31
-$32.96M
2025-12-31
-$6.4M
2025-09-30
-$40.96M
淨利潤率
2026-06-30
-86.06%
2026-03-31
-164.56%
2025-12-31
-27.79%
2025-09-30
-249.38%
每股收益
2026-06-30
$-0.11
2026-03-31
$-0.21
2025-12-31
$-0.04
2025-09-30
$-0.30
息稅折舊攤銷前利潤
2026-06-30
-$45.95M
2026-03-31
-$20.5M
2025-12-31
$6.31M
2025-09-30
-$27.45M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
5.92%
2025-09-30
0.64%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $19.24M | $20.03M | $23.05M | $16.42M |
| 營業支出 | $42.31M | $41.66M | $39.48M | $45.55M |
| 淨利潤 | -$16.56M | -$32.96M | -$6.4M | -$40.96M |
| 淨利潤率 | -86.06% | -164.56% | -27.79% | -249.38% |
| 每股收益 | $-0.11 | $-0.21 | $-0.04 | $-0.30 |
| 息稅折舊攤銷前利潤 | -$45.95M | -$20.5M | $6.31M | -$27.45M |
| 有效稅率 | -- | -- | 5.92% | 0.64% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。